Instant Systems Featured in CoVa BIZ Magazine
Explore how resilient supply chains have become a critical component of success for organizations operating in advanced therapies and other highly regulated industries. As cell and gene therapies continue to evolve, the ability to secure reliable manufacturing partners and establish long-term supply agreements has never been more important. For nearly three decades Instant Systems has […]
What We Learned from the Black Swan Events That Reshaped Supply Chain Planning
For many companies in advanced therapies and medical manufacturing, supply chain disruptions were once viewed primarily as operational inconveniences. Delayed shipments, extended lead times, and material shortages were considered manageable exceptions rather than existential risks. That perspective changed dramatically over the last decade. At Instant Systems, one of the defining moments came in 2011 following […]
Why Supply Agreements Matter More Than Emerging Cell & Gene Therapy Companies Realize
Many emerging cell and gene therapy companies hesitate to enter supply agreements because they believe they are too small, too early-stage, or need maximum flexibility. Some worry that agreements will lock them into long-term pricing or make it harder to adapt as their processes evolve. These concerns are understandable, particularly for organizations navigating clinical growth, […]
What is the Right Filter for your Cell Therapy Manufacturing Process?
Selecting the correct inline filter is critical in the cell therapy manufacturing process to ensure product purity and efficacy. This choice depends on identifying potential contaminants, such as particulates, bacteria, fungi, and viruses, that could compromise the therapy. Filters, typically ranging from 40 microns to 0.2 microns, are designed to target specific contaminants while allowing […]
